The mammalian ortholog of brat, TRIM3, has similarly been shown to reduce MYC and promote differentiation in human glioma cell lines, while a reduced TRIM3 expression has been reported in glioblastoma and is associated with poor survival [69]. Here, TRIM3 is linked to central nervous system cancer.